DNOW shares have fallen 7.2% over the past six months to $12.71, underperforming the S&P 500's 9% gain, as the company faces shrinking operating margins, declining earnings per share, and falling returns on invested capital. Its operating margin decreased by 6.9 percentage points over the last five years, turning negative to negative 4.6% on a trailing 12-month basis. Earnings per share declined 13.9% annually over the last two years even as revenue grew 21.7%, signaling deteriorating profitability. The stock trades at a forward price-to-sales ratio of 0.5 times, but a lack of published earnings estimates makes reliable valuation difficult, leading analysts to recommend avoiding the stock for now.
Now IncArticle reports declining operating margins, falling EPS, and negative ROIC, signaling deteriorating profitability and financial health.